The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review
Open accessAbstract
The World Health Organization/International Society and Federation of Cardiology (WHO/ISFC) task force on the definition and classification of cardiomyopathies recently updated and reclassified heart muscle diseases.1 Myocarditis was defined as “an inflammatory disease of the myocardium . . . diagnosed by established histological, immunological, and immunohistochemical criteria.” Three distinct forms of inflammatory cardiomyopathy (that is, myocarditis associated with cardiac dysfunction) are recognised: idiopathic, autoimmune, and infectious. Various infectious factors may cause myocarditis, but viral agents, especially coxsackie group B viruses, are most commonly associated with this disease.2 Myocarditis has been recognised for almost two centuries, since Corvisart first described this disease in clinical terms in 1812,3 but in the last three decades there has been renewed interest in the inflammatory process in the myocardium. The reasons for this are multiple: the introduction of endomyocardial biopsy for in vivo diagnosis (the disease was often overdiagnosed in the past on purely clinical grounds)4; related efforts to produce standardised criteria for histological diagnosis (the Dallas criteria; fig 1)5; better understanding of cardiotropic viruses, studied in animal models of myocarditis,6 leading to new insights into the immunological mechanisms of the disease (fig2)7 and potential treatments in humans8; and lastly—and perhaps most interestingly—the finding of a possible causal relation between viral myocarditis and dilated cardiomyopathy,9 a major cause of congestive heart failure in western countries. Figure 1 Histological section of active lymphocytic myocarditis according to the Dallas criteria. A dense infiltrate of lymphocytes in close contact with damaged and necrotic myocytes is evident (haematoxylin and eosin × 100). Figure 2 CD4RO positive T lymphocytic cellular infiltrates in a diffuse pattern (× 40). Despite numerous published reports on this disease, the natural history of acute myocarditis is still poorly understood, despite the development of immunological …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myocarditis. A histopathologic definition and classification.
Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallon, J. T., Fenoglio, J. J., Olsen, E. G. J., & Schöen, F. J. (1987) · PubMed · Cited by 1,587
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274 · cited 1×
“This analysis showed variability in spontaneous resolution, with an average of 57% of patients improving with medical treatment and restriction of physical activity alone. These data are in agreement with those observed in the recent myocarditis treatment trial”
ResultLong-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis
McCarthy, R. E., Boehmer, J. P., Hruban, R. H., Hutchins, G. M., Kasper, E. K., Hare, J. M., & Baughman, K. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421003 · Cited by 877
Bowles, N. E., Olsen, E. G. J., Richardson, P. J., & Archard, L. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91837-4 · Cited by 602
Dec, G. W., Palacios, I. F., Fallon, J. T., Aretz, H. T., Mills, J., Lee, D. C.-S., & Johnson, R. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121404 · Cited by 566
HAUCK, A. J., KEARNEY, D. L., & EDWARDS, W. D. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61286-5 · Cited by 437
Diagnosis and Classification of Myocarditis by Endomyocardial Biopsy
Fenoglio, J. J., Ursell, P. C., Kellogg, C. F., Drusin, R. E., & Weiss, M. B. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080103 · Cited by 344
SAKAKIBARA, S., & KONNO, S. (1962) · Japanese Heart Journal · doi:10.1536/ihj.3.537 · Cited by 287
Why, H. J., Meany, B. T., Richardson, P. J., Olsen, E. G., Bowles, N. E., Cunningham, L., Freeke, C. A., & Archard, L. C. (1994) · Circulation · doi:10.1161/01.cir.89.6.2582 · Cited by 272
Morgera, T., Di Lenarda, A., Dreas, L., Pinamonti, B., Humar, F., Bussani, R., Silvestri, F., Chersevani, D., & Camerini, F. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90613-z · Cited by 264
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.
Shanes, J. G., Ghali, J., Billingham, M. E., Ferrans, V. J., Fenoglio, J. J., Edwards, W. D., Tsai, C. C., Saffitz, J. E., Isner, J., & Furner, S. (1987) · Circulation · doi:10.1161/01.cir.75.2.401 · Cited by 253
Viral myocarditis mimicking acute myocardial infarction
Dec, G. W., Waldman, H., Southern, J., Fallon, J. T., Hutter, A. M., & Palacios, I. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90141-9 · Cited by 243
Antibodies to Coxsackie B viruses in congestive cardiomyopathy.
Cambridge, G., MacArthur, C. G., Waterson, A. P., Goodwin, J. F., & Oakley, C. M. (1979) · Heart · doi:10.1136/hrt.41.6.692 · Cited by 241
Coxsackie B myopericarditis in adults
Smith, W. G. (1970) · American Heart Journal · doi:10.1016/0002-8703(70)90035-9 · Cited by 217
Feldman, A. M., Ray, P. E., Silan, C. M., Mercer, J. A., Minobe, W., & Bristow, M. R. (1991) · Circulation · doi:10.1161/01.cir.83.6.1866 · Cited by 203
Matsumori, A., & Kawai, C. (1982) · Circulation · doi:10.1161/01.cir.66.2.355 · Cited by 193
ADULT HEART DISEASE DUE TO THE COXSACKIE VIRUS B INFECTION
SAINANI, G. S., KROMPOTIC, E., & SLODKI, S. J. (1968) · Medicine · doi:10.1097/00005792-196803000-00003 · Cited by 187
Grogan, M., Redfield, M. M., Bailey, K. R., Reeder, G. S., Gersh, B. J., Edwards, W. D., & Rodeheffer, R. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00148-s · Cited by 185
Vignola, P. A., Aonuma, K., Swaye, P. S., Rozanski, J. J., Blankstein, R. L., Benson, J., Gosselin, A. J., & Lister, J. W. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80411-8 · Cited by 167
Sole, M. J., & Liu, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90470-l · Cited by 159
Edwards, W. D., Holmes, D., & Reeder, G. S. (1982) · PubMed · Cited by 158
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.
GShanes, J., JGhali, EBillingham, M., JFerrans, V., JFenoglio, J., DEdwards, W., CTsai, C., ESaffitz, J., JIsner, & SFurner (1987) · Circulation · Cited by 150
Davidoff, R., Palacios, I. F., Southern, J. F., Fallon, J. T., Newell, J. B., & Dec, G. W. (1991) · Circulation · doi:10.1161/01.cir.83.3.953 · Cited by 144
Cunningham, L., Bowles, N. E., Lane, R. J. M., Dubowitz, V., & ARCHARD, L. C. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-6-1399 · Cited by 139
Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.
Weiss, L. M., Movahed, L. A., Billingham, M. E., & Cleary, M. L. (1991) · PubMed Central · Cited by 117
Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies
Martino, T. A., Liu, P. X., Petric, M., & Sole, M. J. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch14 · Cited by 107
Cardiac Manifestations During a Coxsackie B5 Epidemic
Helin, M., Savola, J., & LAPINLEIMU, K. (1968) · BMJ · doi:10.1136/bmj.3.5610.97 · Cited by 107
Children may survive severe myocarditis with prolonged use of biventricular assist devices
Stiller, B., Dähnert, I., Weng, Y., Hennig, E., Hetzer, R., & Lange, P. (1999) · Heart · doi:10.1136/hrt.82.2.237 · Cited by 93
Giacca, M., Severini, G. M., Mestroni, L., Salvi, A., Lardieri, G., Falaschi, A., & Camerini, F. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90866-4 · Cited by 83
Herskowitz, A., Campbell, S., Deckers, J. W., Kasper, E. K., BOEHMER, J. P., Hadian, D., Neumann, D. A., & Baughman, K. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90918-3 · Cited by 79
Figulla, H. R., Stille‐Siegener, M., Mall, G., Heim, A., & Kreuzer, H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00517-t · Cited by 70
Immunosuppressive treatment for myocarditis and dilated cardiomyopathy
Maisch, B., Herzum, M., Hufnagel, G., et al. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_o.153 · Cited by 58
Clinical outcome and left ventricular function 23 years after acute Coxsackie virus myopericarditis
Remes, J., Helin, M., VAINO, P., & Rautio, P. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059675 · Cited by 51
Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial.
Maisch, B., Schönian, U., Hengstenberg, C., Herzum, M., Hufnagel, G., Bethge, C., Bittinger, A., & Neumann, K. (1994) · PubMed · Cited by 44
Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease.
Craighead, J. E., Huber, S. A., & Sriram, S. (1990) · PubMed · Cited by 44
Cappato, R., Codecà, L., Guardigli, G., Toselli, T., Antonioli, G., & Alboni, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90822-i · Cited by 39
Coxsackie virus heart disease and cardiomyopathy
Levi, G., Proto, C., Quadri, A., & Ratti, S. (1977) · American Heart Journal · doi:10.1016/s0002-8703(77)80402-x · Cited by 36
ACE inhibitors for myocardial infarction: how should they be used?
Cleland, J. G. F. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060879 · Cited by 33
Anderson, J. L., Fowles, R. E., Unverrerth, D. V., & Mason, J. W. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_j.263 · Cited by 29
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Metadata
- Authors
- D'Ambrosio, A.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2001-05-01
- Volume
- 85
- Issue
- 5
- Pages
- 499-504
- ISSN
- 0007-0769 (ISSN-L)
- OpenAlex
- W2169785058
- Cited by
- 288
- References
- 40
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.